Francesco Lo Monaco: The Supplement You Take for Your Heart Could Be the One Increasing Your Risk of a Heart Attack
Francesco Lo Monaco, Cardiologist and Founder of The National Heart Clinic, posted on LinkedIn:
“The supplement you take for your heart could be the one increasing your risk of a heart attack.
People trying to do the right thing for their health… taking supplements they believe are protective…
and unintentionally increasing their cardiovascular risk instead.
Here’s what many don’t know:
- Calcium on its own.
High-dose calcium without vitamin D can do the opposite of what you expect, instead of strengthening your bones, it may harden your arteries.
Studies show up to a 30% higher risk of heart attack with calcium alone.
When vitamin D is added, that risk disappears. - Niacin (Vitamin B3)
Once seen as “heart-protective”, niacin in high doses can trigger inflammation inside blood vessels, doubling heart attack and stroke risk.
Ironically, it cancels out the very benefit it’s meant to give. - Fish Oil
If you already have heart disease, fish oil might help.
But if your heart is healthy, regular excessive use can increase the risk of irregular heartbeats. - Red Yeast Rice and ‘Natural’ Heart Supplements.
Many of these contain the same active compounds as prescription statins, without proper monitoring.
That means possible muscle damage, toxicity, or dangerous interactions if you’re already on medication.
My advice:
Supplements are good but they can have real effects, and sometimes, real risks.
Before starting anything, ask yourself:
→ Do I actually need this?
→ Is it based on my blood work and clinical context?
→ Am I combining it safely with other treatments?
Because prevention is powerful, but only when it’s personalised and guided by data.
If you’re investing in your health and longevity, make sure your supplements are helping, not silently harming.”

Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies